je.st
news
New Zealand Biotech Firm Gets U.S. Funding for Promising Multiple Sclerosis Drug
2013-10-14 06:06:15| Biotech - Topix.net
A New Zealand biotechnology company, CuroNZ, received funding from the US National Multiply Sclerosis Society worth $540,000 to be used in pre-clinical studies.
Tags: multiple
firm
drug
zealand
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|